I'm glad you're here to answer questions if you will, please! 1. How do we know how strong the first cohort dose was ? Why would this be privy or non privy information. I would believe that Dr. Menon would have given some input to this decision based on his knowledge of kevetrin in the lab.This hopefully was a strong enough dose to show markers which will give us information to go with when the first blood work is announced. 2. Why should we wait to be diagnosed with cancer before being treated with Kevetrin? An apple a day...Kevetrin a day! Thank you, thank you very much.